SUDOSCAN Inc. (subsidiary of Impeto Medical SAS)

SUDOSCAN Inc. manufactures and distributes the SUDOSCAN device, a Class IIa medical device for early detection and monitoring of peripheral autonomic neuropathies and small fiber neuropathy. The device uses electrochemical skin conductance (ESC) measurement via electrode stimulation of sweat glands to assess sudomotor function and autonomic nerve fiber integrity. A non-invasive test completed in under 3 minutes with no patient preparation required, SUDOSCAN is indicated for diabetic neuropathy screening, chemotherapy-induced peripheral neuropathy (CIPN) monitoring, and evaluation of neuropathies associated with amyloidosis, Sjögren's syndrome, Fabry disease, Hepatitis C, and other neurological conditions. The device consists of a computer system with four electrodes where patients place hands and feet; results are automatically displayed as electrochemical skin conductance scores indicating presence and severity of autonomic dysfunction. Manufactured by parent company Impeto Medical SAS (France headquarters), SUDOSCAN has sold over 5,000 devices worldwide and is included in clinical guidelines from the European Network for TTR-FAP Amyloidosis, German diabetes management guidelines, and Latin American diabetes associations. CE-marked and FDA-cleared for use. The company also offers SudoCloud, a secure cloud-based remote patient monitoring platform for connecting, retrieving, and managing patient data. Clinical evidence includes 150+ peer-reviewed journal publications supporting reliability and diagnostic utility across multiple therapeutic areas.